Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

Automated sample handling, advanced glycan analysis, and specially designed columns are help speed up confirmation of the biosimilarity.

Advances in UPLC Techniques and Column Chemistry Aid the Confirmation of Biosimilarity

John Schmitz, director of strategy and business development, life sciences, Saint-Gobain Performance Plastics.

Consider these best practices when deciding to implement single-use components.

Selecting Single-Use Systems for Biopharmaceutical Manufacturing

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

Disposable Applications in Demand by Biopharma

FDA updates guidance to reflect advances in technology.

FDA Reissues Bioanalytical Method Validation Guidance

Shimadzu's LCMS-8040 combines newly improved ion optics and collision cell technology with proprietary ultrafast technologies.

The world's fastest LCMS/MS tandem mass spectrometer

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

35th Anniversary Special: The Today and Tomorrow of Process Analytical Technology

Industry wants more innovation, but can suppliers meet customer needs?

Biomanufacturing Innovation

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Critical issues that should be considered when scaling up a hot-melt extrusion process.

Scale-up Challenges in Hot-Melt Extrusion

Amy Ritter was Scientific Editor, BioPharm International.

On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount.

Manufacturing Equipment, Downstream Processing